Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Shire Human Genetic Therapies AB
AB
Dissolved
Org 5565911764
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2000
3 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Shire Human Genetic Therapies AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AJ
Anders Joakim Toivo Taaler
Chief Auditor
Chief Auditor
2022
Former (1)
RH
Resul Hamurcu
Chief Auditor
Chief Auditor
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
PN
Per Niklas William Rydingsvärd
Board of Directors
2020
RK
Roland Kurney
Chairman
2025
ST
Sofia Therese Hultman
Board of Directors
2024
Former (3)
KS
Koki Sato
Board of Directors
2024 – 2025
VM
Vatroslav Mateljic
Chairman
2020 – 2024
ØL
Øyvind Løkeberg
Board of Directors
2020 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
SHIRE HUMAN GENETIC THERAPIES INC
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Shire Human Genetic Therapies AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot